Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.69 |
| ▸ | AHR | P35869 | 2/20 | 0.62 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.58 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.54 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.54 |
| ▸ | PCSK9 | Q8NBP7 | 5/20 | 0.53 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.52 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29403791 | 1.00 | LOXL2 (0.69) | LOXL2AHRHRH3MTNR1AMTNR1B | |
| SCHEMBL401081 | 1.00 | LOXL2 (0.69) | LOXL2AHRHRH3MTNR1AMTNR1B | |
| SCHEMBL28335219 | 0.98 | LOXL2 (0.67) | LOXL2AHRHRH3MTNR1AMTNR1B | |
| SCHEMBL7169246 | 0.91 | LOXL2 (0.69) | LOXL2AHRHRH3MTNR1AMTNR1B | |
| SCHEMBL31059889 | 0.91 | LOXL2 (0.69) | LOXL2AHRHRH3MTNR1AMTNR1B | |
| SCHEMBL30105384 | 0.87 | LOXL2 (0.60) | LOXL2AHRPCSK9 | |
| SCHEMBL3193871 | 0.87 | LOXL2 (0.60) | LOXL2AHRPCSK9 | |
| SCHEMBL17508513 | 0.87 | AHR (0.55) | LOXL2AHRHRH3MTNR1AMTNR1B | |
| SCHEMBL6860219 | 0.86 | LOXL2 (0.64) | LOXL2AHRHRH3MTNR1AMTNR1B | |
| Bromide SCHEMBL30437340 | 0.86 | LOXL2 (0.58) | LOXL2AHRPCSK9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110446505-A | Combination therapy for treating skin disorders | SKINTECH LIFE SCIENCE LTD | 2019-11-12 | — | — | CN | disclosed |